Further investigation of the HCC category highlighted enriched pathway maps, including immune responses mediated by IL-6/JAK/STAT signaling, cell cycle regulation of SCF complex and G1/S transition, and DNA damage response pathways (Fig. 1F). Here, IL6 is linked to hepatocellular carcinoma.